Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Cavedini, P; Riboldi, G; D'Annucci, A; Belotti, P; Cisima, M; Bellodi, L
   Decision-making heterogeneity in obsessive-compulsive disorder: Ventromedial prefrontal cortex function predicts different treatment outcomes
   NEUROPSYCHOLOGIA
   
   P. Cavedini et al., "Decision-making heterogeneity in obsessive-compulsive disorder: Ventromedial prefrontal cortex function predicts different treatment outcomes", NEUROPSYCHO, 40(2), 2002, pp. 205-211
2. Stangier, U; Hungerbuhler, R
   Imagined ugliness: Body dysmorphic disorder from a psychological view
   ZEITSCHRIFT FUR KLINISCHE PSYCHOLOGIE UND PSYCHOTHERAPIE
   
   U. Stangier e R. Hungerbuhler, "Imagined ugliness: Body dysmorphic disorder from a psychological view", Z KLIN P P, 30(2), 2001, pp. 77-83
3. Ecker, W
   The relevance of memory processes for the understanding of compulsive checking
   ZEITSCHRIFT FUR KLINISCHE PSYCHOLOGIE UND PSYCHOTHERAPIE
   
   W. Ecker, "The relevance of memory processes for the understanding of compulsive checking", Z KLIN P P, 30(1), 2001, pp. 45-54
4. Calder, AJ; Lawrence, AD; Young, AW
   Neuropsychology of fear and loathing
   NATURE REVIEWS NEUROSCIENCE
   
   A.J. Calder et al., "Neuropsychology of fear and loathing", NAT REV NEU, 2(5), 2001, pp. 352-363
5. Matsunaga, H; Kiriike, N; Matsui, T; Iwasaki, Y; Stein, DJ
   Taijin kyofusho: a form of social anxiety disorder that responds to serotonin reuptake inhibitors
   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
   
   H. Matsunaga et al., "Taijin kyofusho: a form of social anxiety disorder that responds to serotonin reuptake inhibitors", IN J NEUROP, 4(3), 2001, pp. 231-237
6. McCall, WV
   Electroconvulsive thera in the era of modern psychopharmacology
   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
   
   W.V. McCall, "Electroconvulsive thera in the era of modern psychopharmacology", IN J NEUROP, 4(3), 2001, pp. 315-324
7. March, JS; Vitiello, B
   Advances in paediatric neuropsychopharmacology: an overview
   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
   
   J.S. March e B. Vitiello, "Advances in paediatric neuropsychopharmacology: an overview", IN J NEUROP, 4(2), 2001, pp. 141-147
8. Geller, DA; Biederman, J; Faraone, SV; Bellordre, CA; Kim, GS; Hagermoser, L; Cradock, K; Frazier, J; Coffey, BJ
   Disentangling chronological age from age of onset in children and adolescents with obsessive-compulsive disorder
   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
   
   D.A. Geller et al., "Disentangling chronological age from age of onset in children and adolescents with obsessive-compulsive disorder", IN J NEUROP, 4(2), 2001, pp. 169-178
9. Rosenberg, DR; MacMillan, SN; Moore, GJ
   Brain anatomy and chemistry may predict treatment response in paediatric obsessive-compulsive disorder
   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
   
   D.R. Rosenberg et al., "Brain anatomy and chemistry may predict treatment response in paediatric obsessive-compulsive disorder", IN J NEUROP, 4(2), 2001, pp. 179-190
10. Leonard, HL; Swedo, SE
    Paediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS)
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
    
    H.L. Leonard e S.E. Swedo, "Paediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS)", IN J NEUROP, 4(2), 2001, pp. 191-198
11. Kuchenhoff, J
    Perspectives of psychoanalytic psychosomatics
    ZEITSCHRIFT FUR PSYCHOSOMATISCHE MEDIZIN UND PSYCHOTHERAPIE
    
    J. Kuchenhoff, "Perspectives of psychoanalytic psychosomatics", Z PSYCHOS M, 47(4), 2001, pp. 396-410
12. Wassermann, EM; Lisanby, SH
    Therapeutic application of repetitive transcranial magnetic stimulation: areview
    CLINICAL NEUROPHYSIOLOGY
    
    E.M. Wassermann e S.H. Lisanby, "Therapeutic application of repetitive transcranial magnetic stimulation: areview", CLIN NEU, 112(8), 2001, pp. 1367-1377
13. Rouillon, F
    Depression comorbid with anxiety or medical illness: The role of paroxetine
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    
    F. Rouillon, "Depression comorbid with anxiety or medical illness: The role of paroxetine", INT J PSYC, 5(1), 2001, pp. 3-10
14. Posner, MI; Rothbart, MK; Farah, M; Bruer, J
    Special issue: The developing human brain
    DEVELOPMENTAL SCIENCE
    
    M.I. Posner et al., "Special issue: The developing human brain", DEV SCI, 4(3), 2001, pp. 253-387
15. Grachev, ID; Kumar, R; Ramachandran, TS; Szeverenyi, NM
    Cognitive interference is associated with neuronal marker N-acetyl aspartate in the anterior cingulate cortex: an in vivo H-1-MRS study of the StroopColor-Word task
    MOLECULAR PSYCHIATRY
    
    I.D. Grachev et al., "Cognitive interference is associated with neuronal marker N-acetyl aspartate in the anterior cingulate cortex: an in vivo H-1-MRS study of the StroopColor-Word task", MOL PSYCHI, 6(5), 2001, pp. 529-539
16. Serretti, A; Zanardi, R; Rossini, D; Cusin, C; Lilli, R; Smeraldi, E
    Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity
    MOLECULAR PSYCHIATRY
    
    A. Serretti et al., "Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity", MOL PSYCHI, 6(5), 2001, pp. 586-592
17. Veenstra-VanderWeele, J; Kim, SJ; Gonen, D; Hanna, GL; Leventhal, BL; Cook, EH
    Genomic organization of the SLC1A1/EAAC1 gene and mutation screening in early-onset obsessive-compulsive disorder
    MOLECULAR PSYCHIATRY
    
    J. Veenstra-VanderWeele et al., "Genomic organization of the SLC1A1/EAAC1 gene and mutation screening in early-onset obsessive-compulsive disorder", MOL PSYCHI, 6(2), 2001, pp. 160-167
18. Seeger, G; Schloss, P; Schmidt, MH
    Functional polymorphism within the promotor of the serotonin transporter gene is associated with severe hyperkinetic disorders
    MOLECULAR PSYCHIATRY
    
    G. Seeger et al., "Functional polymorphism within the promotor of the serotonin transporter gene is associated with severe hyperkinetic disorders", MOL PSYCHI, 6(2), 2001, pp. 235-238
19. Lochner, C; Vythilingum, B; Stein, DJ
    Olfactory reference syndrome: diagnostic criteria and differential diagnosis
    PRIMARY CARE PSYCHIATRY
    
    C. Lochner et al., "Olfactory reference syndrome: diagnostic criteria and differential diagnosis", PRIM CARE P, 7(2), 2001, pp. 55-59
20. Pandit, SA; Argyropoulos, S; Nutt, DJ
    Current status of anxiolytic drugs
    PRIMARY CARE PSYCHIATRY
    
    S.A. Pandit et al., "Current status of anxiolytic drugs", PRIM CARE P, 7(1), 2001, pp. 1-5
21. Emsley, R; Oosthuizen, P; Niehaus, D; Stein, D
    Anxiety symptoms in schizophrenia: the need for heightened clinician awareness
    PRIMARY CARE PSYCHIATRY
    
    R. Emsley et al., "Anxiety symptoms in schizophrenia: the need for heightened clinician awareness", PRIM CARE P, 7(1), 2001, pp. 25-29
22. Miwa, H; Miwa, T; Imai, H; Mizuno, Y
    Obsessive-compulsive-like behavioral changes in pure akinesia
    PARKINSONISM & RELATED DISORDERS
    
    H. Miwa et al., "Obsessive-compulsive-like behavioral changes in pure akinesia", PARKINS R D, 7(4), 2001, pp. 315-317
23. Coetzer, R; Stein, DJ; Du Toit, PL
    Executive function in traumatic brain injury and obsessive-compulsive disorder: An overlap?
    PSYCHIATRY AND CLINICAL NEUROSCIENCES
    
    R. Coetzer et al., "Executive function in traumatic brain injury and obsessive-compulsive disorder: An overlap?", PSY CLIN N, 55(2), 2001, pp. 83-87
24. Stein, MB; Gorman, JM
    Unmasking social anxiety disorder
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    
    M.B. Stein e J.M. Gorman, "Unmasking social anxiety disorder", J PSYCH NEU, 26(3), 2001, pp. 185-189
25. Li, D; Chokka, P; Tibbo, P
    Toward an integrative understanding of social phobia
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    
    D. Li et al., "Toward an integrative understanding of social phobia", J PSYCH NEU, 26(3), 2001, pp. 190-202
26. Grzella, I; Muller, BW; Oades, RD; Bender, S; Schall, U; Zerbin, D; Wolstein, J; Sartory, G
    Novelty-elicited mismatch negativity in patients with schizophrenia on admission and discharge
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    
    I. Grzella et al., "Novelty-elicited mismatch negativity in patients with schizophrenia on admission and discharge", J PSYCH NEU, 26(3), 2001, pp. 235-246
27. Blier, P; Abbott, FV
    Putative mechanisms of action of antidepressant drugs in affective and anxiety disorders and pain
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    
    P. Blier e F.V. Abbott, "Putative mechanisms of action of antidepressant drugs in affective and anxiety disorders and pain", J PSYCH NEU, 26(1), 2001, pp. 37-43
28. Khullar, A; Chue, P; Tibbo, P
    Quetiapine and obsessive-compulsive symptoms (OCS): case report and reviewof atypical antipsychotic-induced OCS
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    
    A. Khullar et al., "Quetiapine and obsessive-compulsive symptoms (OCS): case report and reviewof atypical antipsychotic-induced OCS", J PSYCH NEU, 26(1), 2001, pp. 55-59
29. Arnold, LM; Auchenbach, MB; McElroy, SL
    Psychogenic excoriation - Clinical features, proposed diagnostic criteria,epidemiology and approaches to treatment
    CNS DRUGS
    
    L.M. Arnold et al., "Psychogenic excoriation - Clinical features, proposed diagnostic criteria,epidemiology and approaches to treatment", CNS DRUGS, 15(5), 2001, pp. 351-359
30. Brambilla, F
    Aetiopathogenesis and pathophysiology of bulimia nervosa - Biological bases and implications for treatment
    CNS DRUGS
    
    F. Brambilla, "Aetiopathogenesis and pathophysiology of bulimia nervosa - Biological bases and implications for treatment", CNS DRUGS, 15(2), 2001, pp. 119-136
31. Himmelhoch, J; Levine, J; Gershon, S
    Historical overview of the relationship between anxiety disorders and affective disorders
    DEPRESSION AND ANXIETY
    
    J. Himmelhoch et al., "Historical overview of the relationship between anxiety disorders and affective disorders", DEPRESS ANX, 14(2), 2001, pp. 53-66
32. Ninan, PT; Berger, J
    Symptomatic and syndromal anxiety and depression
    DEPRESSION AND ANXIETY
    
    P.T. Ninan e J. Berger, "Symptomatic and syndromal anxiety and depression", DEPRESS ANX, 14(2), 2001, pp. 79-85
33. Levine, J; Cole, DP; Chengappa, KNR; Gershon, S
    Anxiety disorders and major depression, together or apart
    DEPRESSION AND ANXIETY
    
    J. Levine et al., "Anxiety disorders and major depression, together or apart", DEPRESS ANX, 14(2), 2001, pp. 94-104
34. Levine, J; Chengappa, KNR; Gershon, S; Drevets, W
    Differentiating primary pathophysiologic from secondary adaptational processes
    DEPRESSION AND ANXIETY
    
    J. Levine et al., "Differentiating primary pathophysiologic from secondary adaptational processes", DEPRESS ANX, 14(2), 2001, pp. 105-111
35. Himle, JA; Rassi, S; Haghighatgou, H; Krone, KP; Nesse, RM; Abelson, J
    Group behavioral therapy of Obsessive-Compulsive Disorder: Seven vs. twelve-week outcomes
    DEPRESSION AND ANXIETY
    
    J.A. Himle et al., "Group behavioral therapy of Obsessive-Compulsive Disorder: Seven vs. twelve-week outcomes", DEPRESS ANX, 13(4), 2001, pp. 161-165
36. Dunner, DL
    Management of anxiety disorders: The added challenge of comorbidity
    DEPRESSION AND ANXIETY
    
    D.L. Dunner, "Management of anxiety disorders: The added challenge of comorbidity", DEPRESS ANX, 13(2), 2001, pp. 57-71
37. Russell, JM; Koran, LM; Rush, J; Hirschfeld, RMA; Harrison, W; Friedman, ES; Davis, S; Keller, M
    Effect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depression
    DEPRESSION AND ANXIETY
    
    J.M. Russell et al., "Effect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depression", DEPRESS ANX, 13(1), 2001, pp. 18-27
38. Overall, KL
    Pharmacological treatment in behavioural medicine: The importance of neurochemistry, molecular biology and mechanistic hypotheses
    VETERINARY JOURNAL
    
    K.L. Overall, "Pharmacological treatment in behavioural medicine: The importance of neurochemistry, molecular biology and mechanistic hypotheses", VET J, 162(1), 2001, pp. 9-23
39. McGovern, J; Turkington, D
    'Seeing the wood from the trees': A continuum model of psychopathology advocating cognitive behaviour therapy for schizophrenia
    CLINICAL PSYCHOLOGY & PSYCHOTHERAPY
    
    J. McGovern e D. Turkington, "'Seeing the wood from the trees': A continuum model of psychopathology advocating cognitive behaviour therapy for schizophrenia", CLIN PSY PS, 8(3), 2001, pp. 149-175
40. Ben-Zion, IZ; Meiri, G; Shiber, A; Buskila, D; Benjamin, J
    Serotonin blockade does not affect nonarticular tenderness in healthy volunteers
    JOURNAL OF MUSCULOSKELETAL PAIN
    
    I.Z. Ben-Zion et al., "Serotonin blockade does not affect nonarticular tenderness in healthy volunteers", J MUSCULO P, 9(3), 2001, pp. 43-49
41. State, MW; Pauls, DL; Leckman, JF
    Tourette's syndrome and related disorders
    CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA
    
    M.W. State et al., "Tourette's syndrome and related disorders", CH ADOLESC, 10(2), 2001, pp. 317
42. Chiavaras, MM; LeGoualher, G; Evans, A; Petrides, M
    Three-dimensional probabilistic atlas of the human orbitofrontal sulci in standardized stereotaxic space
    NEUROIMAGE
    
    M.M. Chiavaras et al., "Three-dimensional probabilistic atlas of the human orbitofrontal sulci in standardized stereotaxic space", NEUROIMAGE, 13(3), 2001, pp. 479-496
43. Wewetzer, C; Jans, T; Muller, B; Neudorfl, A; Bucherl, U; Remschmidt, H; Warnke, A; Herpertz-Dahlmann, B
    Long-term outcome and prognosis of obsessive-compulsive disorder with onset in childhood or adolescence
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY
    
    C. Wewetzer et al., "Long-term outcome and prognosis of obsessive-compulsive disorder with onset in childhood or adolescence", EUR CHILD A, 10(1), 2001, pp. 37-46
44. Ruppert, S; Zaudig, M; Hauke, W; Thora, C; Reinecker, HS
    Comorbidity and obsessive-compulsive disorders. Part I: Axis I comorbidity
    VERHALTENSTHERAPIE
    
    S. Ruppert et al., "Comorbidity and obsessive-compulsive disorders. Part I: Axis I comorbidity", VERHALTENST, 11(2), 2001, pp. 104-111
45. Ruppert, S; Zaudig, M; Reinecker, HS; Thora, C; Hauke, W
    Comorbidity and obsessive-compulsive disorders. Part II: Axis II comorbidity
    VERHALTENSTHERAPIE
    
    S. Ruppert et al., "Comorbidity and obsessive-compulsive disorders. Part II: Axis II comorbidity", VERHALTENST, 11(2), 2001, pp. 112-118
46. Ruhmland, M; Margraf, J
    Efficacy of psychological treatments for specific phobia and obsessive compulsive disorder
    VERHALTENSTHERAPIE
    
    M. Ruhmland e J. Margraf, "Efficacy of psychological treatments for specific phobia and obsessive compulsive disorder", VERHALTENST, 11(1), 2001, pp. 14-26
47. Pace-Schott, EF; Gersh, T; Silvestri, R; Stickgold, R; Salzman, C; Hobson, JA
    SSRI Treatment suppresses dream recall frequency but increases subjective dream intensity in normal subjects
    JOURNAL OF SLEEP RESEARCH
    
    E.F. Pace-Schott et al., "SSRI Treatment suppresses dream recall frequency but increases subjective dream intensity in normal subjects", J SLEEP RES, 10(2), 2001, pp. 129-142
48. Murphy, CA; Heidbreder, C; Feldon, J
    Acute withdrawal from repeated cocaine treatment enhances latent inhibition of a conditioned fear response
    BEHAVIOURAL PHARMACOLOGY
    
    C.A. Murphy et al., "Acute withdrawal from repeated cocaine treatment enhances latent inhibition of a conditioned fear response", BEHAV PHARM, 12(1), 2001, pp. 13-23
49. Phillips, KA; Crino, RD
    Body dysmorphic disorder
    CURRENT OPINION IN PSYCHIATRY
    
    K.A. Phillips e R.D. Crino, "Body dysmorphic disorder", CUR OPIN P, 14(2), 2001, pp. 113-118
50. Fenton, WS
    Comorbid conditions in schizophrenia
    CURRENT OPINION IN PSYCHIATRY
    
    W.S. Fenton, "Comorbid conditions in schizophrenia", CUR OPIN P, 14(1), 2001, pp. 17-23
51. Altamura, C; Paluello, MM; Mundo, E; Medda, S; Mannu, P
    Clinical and subclinical body dysmorphic disorder
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
    
    C. Altamura et al., "Clinical and subclinical body dysmorphic disorder", EUR ARCH PS, 251(3), 2001, pp. 105-108
52. Grabe, HJ; Meyer, C; Hapke, U; Rumpf, HJ; Freyberger, HJ; Dilling, H; John, U
    Lifetime-comorbidity of obsessive-compulsive disorder and subclinical obsessive-compulsive disorder in northern Germany
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
    
    H.J. Grabe et al., "Lifetime-comorbidity of obsessive-compulsive disorder and subclinical obsessive-compulsive disorder in northern Germany", EUR ARCH PS, 251(3), 2001, pp. 130-135
53. Liebler, A
    "Sitting in my castle while a war rages outside". Social isolation and theneed for delimitation as aspects relevant of obsessive-compulsive disorders
    PSYCHOTHERAPEUT
    
    A. Liebler, ""Sitting in my castle while a war rages outside". Social isolation and theneed for delimitation as aspects relevant of obsessive-compulsive disorders", PSYCHOTHERA, 46(3), 2001, pp. 182-187
54. Takano, A; Shiga, T; Kitagawa, N; Koyama, T; Katoh, C; Tsukamoto, E; Tamaki, N
    Abnormal neuronal network in anorexia nervosa studied with I-123-IMP SPECT
    PSYCHIATRY RESEARCH-NEUROIMAGING
    
    A. Takano et al., "Abnormal neuronal network in anorexia nervosa studied with I-123-IMP SPECT", PSYCH RES-N, 107(1), 2001, pp. 45-50
55. Deicken, RF; Eliaz, Y; Feiwell, R; Schuff, N
    Increased thalamic N-acetylaspartate in male patients with familial bipolar I disorder
    PSYCHIATRY RESEARCH-NEUROIMAGING
    
    R.F. Deicken et al., "Increased thalamic N-acetylaspartate in male patients with familial bipolar I disorder", PSYCH RES-N, 106(1), 2001, pp. 35-45
56. Catalano, M
    Functionally gene-linked polymorphic regions and genetically controlled neurotransmitters metabolism
    EUROPEAN NEUROPSYCHOPHARMACOLOGY
    
    M. Catalano, "Functionally gene-linked polymorphic regions and genetically controlled neurotransmitters metabolism", EUR NEUROPS, 11(6), 2001, pp. 431-439
57. Serretti, A; Zanardi, R; Cusin, C; Rossini, D; Lorenzi, C; Smeraldi, E
    Tryptophan hydroxylase gene associated with paroxetine antidepressant activity
    EUROPEAN NEUROPSYCHOPHARMACOLOGY
    
    A. Serretti et al., "Tryptophan hydroxylase gene associated with paroxetine antidepressant activity", EUR NEUROPS, 11(5), 2001, pp. 375-380
58. Tardito, D; Maina, G; Tura, GB; Bogetto, F; Pioli, R; Ravizza, L; Racagni, G; Perez, J
    The cAMP-dependent protein kinase substrate Rap1 in platelets from patients with obsessive compulsive disorder or schizophrenia
    EUROPEAN NEUROPSYCHOPHARMACOLOGY
    
    D. Tardito et al., "The cAMP-dependent protein kinase substrate Rap1 in platelets from patients with obsessive compulsive disorder or schizophrenia", EUR NEUROPS, 11(3), 2001, pp. 221-225
59. Bobes, J; Gonzalez, MP; Bascaran, MT; Arango, C; Saiz, PA; Bousono, M
    Quality of life and disability in patients with obsessive-compulsive disorder
    EUROPEAN PSYCHIATRY
    
    J. Bobes et al., "Quality of life and disability in patients with obsessive-compulsive disorder", EUR PSYCHIA, 16(4), 2001, pp. 239-245
60. Avila, M; Thaker, G; Adami, H
    Genetic epidemiology and schizophrenia: A study of reproductive fitness
    SCHIZOPHRENIA RESEARCH
    
    M. Avila et al., "Genetic epidemiology and schizophrenia: A study of reproductive fitness", SCHIZOPHR R, 47(2-3), 2001, pp. 233-241
61. Stephane, M; Polis, I; Barton, SN
    A subtype of auditory verbal hallucinations responds to fluvoxamine
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
    
    M. Stephane et al., "A subtype of auditory verbal hallucinations responds to fluvoxamine", J NEUROP CL, 13(3), 2001, pp. 425-427
62. Nyffeler, T; Regard, M
    Kleptomania in a patient with a right frontolimbic lesion
    NEUROPSYCHIATRY NEUROPSYCHOLOGY AND BEHAVIORAL NEUROLOGY
    
    T. Nyffeler e M. Regard, "Kleptomania in a patient with a right frontolimbic lesion", NEUROPS NEU, 14(1), 2001, pp. 73-76
63. Mundo, E; Zai, G; Lee, L; Parikh, SV; Kennedy, JL
    The 5HT1D beta receptor gene in Bipolar Disorder: A family-based association study
    NEUROPSYCHOPHARMACOLOGY
    
    E. Mundo et al., "The 5HT1D beta receptor gene in Bipolar Disorder: A family-based association study", NEUROPSYCH, 25(4), 2001, pp. 608-613
64. Erzegovesi, S; Martucci, L; Henin, M; Bellodi, L
    Low versus standard dose mCPP challenge in obsessive-compulsive patients
    NEUROPSYCHOPHARMACOLOGY
    
    S. Erzegovesi et al., "Low versus standard dose mCPP challenge in obsessive-compulsive patients", NEUROPSYCH, 24(1), 2001, pp. 31-36
65. Durston, S; Pol, HEH; Casey, BJ; Giedd, JN; Buitelaar, JK; van Engeland, H
    Anatomical MRI of the developing human brain: What have we learned?
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
    
    S. Durston et al., "Anatomical MRI of the developing human brain: What have we learned?", J AM A CHIL, 40(9), 2001, pp. 1012-1020
66. Woodward, LJ; Fergusson, DM
    Life course outcomes of young people with anxiety disorders in adolescence
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
    
    L.J. Woodward e D.M. Fergusson, "Life course outcomes of young people with anxiety disorders in adolescence", J AM A CHIL, 40(9), 2001, pp. 1086-1093
67. Tolin, DF
    Case study: Bibliotherapy and extinction treatment of obsessive-compulsivedisorder in a 5-year-old boy
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
    
    D.F. Tolin, "Case study: Bibliotherapy and extinction treatment of obsessive-compulsivedisorder in a 5-year-old boy", J AM A CHIL, 40(9), 2001, pp. 1111-1114
68. Thomsen, PH; Ebbesen, C; Persson, C
    Long-term experience with citalopram in the treatment of adolescent OCD
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
    
    P.H. Thomsen et al., "Long-term experience with citalopram in the treatment of adolescent OCD", J AM A CHIL, 40(8), 2001, pp. 895-902
69. Bolton, J; Moore, GJ; MacMillan, S; Stewart, CM; Rosenberg, DR
    Case study: Caudate glutamatergic changes with paroxetine persist after medication discontinuation in pediatric OCD
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
    
    J. Bolton et al., "Case study: Caudate glutamatergic changes with paroxetine persist after medication discontinuation in pediatric OCD", J AM A CHIL, 40(8), 2001, pp. 903-906
70. Wehr, AM; Namerow, LB
    Citalopram for OCD and Tourette's syndrome
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
    
    A.M. Wehr e L.B. Namerow, "Citalopram for OCD and Tourette's syndrome", J AM A CHIL, 40(7), 2001, pp. 740-741
71. Geller, DA; Hoog, SL; Heiligenstein, JH; Ricardi, RK; Tamura, R; Kluszynski, S; Jacobson, JG
    Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: A placebo-controlled clinical trial
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
    
    D.A. Geller et al., "Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: A placebo-controlled clinical trial", J AM A CHIL, 40(7), 2001, pp. 773-779
72. Peterson, BS; Pine, DS; Cohen, P; Brook, JS
    Prospective, longitudinal study of tic, obsessive-compulsive, and attention-deficit/hyperactivity disorders in an epidemiological sample
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
    
    B.S. Peterson et al., "Prospective, longitudinal study of tic, obsessive-compulsive, and attention-deficit/hyperactivity disorders in an epidemiological sample", J AM A CHIL, 40(6), 2001, pp. 685-695
73. Compton, SN; Grant, PJ; Chrisman, AK; Gammon, PJ; Brown, VL; March, JS
    Sertraline in children and adolescents with social anxiety disorder: An open trial
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
    
    S.N. Compton et al., "Sertraline in children and adolescents with social anxiety disorder: An open trial", J AM A CHIL, 40(5), 2001, pp. 564-571
74. Busatto, GF; Buchpiguel, CA; Zamignani, DR; Garrido, GEJ; Glabus, MF; Rosario-Campos, MC; Castro, CC; Maia, A; Rocha, ET; McGuire, PK; Miguel, EC
    Regional cerebral blood flow abnormalities in early-onset obsessive-compulsive disorder: An exploratory SPECT study
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
    
    G.F. Busatto et al., "Regional cerebral blood flow abnormalities in early-onset obsessive-compulsive disorder: An exploratory SPECT study", J AM A CHIL, 40(3), 2001, pp. 347-354
75. Riddle, MA; Reeve, EA; Yaryura-Tobias, JA; Yang, HM; Claghorn, JL; Gaffney, G; Greist, JH; Holland, D; McConville, BJ; Pigott, T; Walkup, JT
    Fluvoxamine for children and adolescents with obsessive-compulsive disorder: A randomized, controlled, multicenter trial
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
    
    M.A. Riddle et al., "Fluvoxamine for children and adolescents with obsessive-compulsive disorder: A randomized, controlled, multicenter trial", J AM A CHIL, 40(2), 2001, pp. 222-229
76. Swedo, SE
    Genetics of childhood disorders: XXXIII. Autoimmunity, Part 6: Poststreptococcal autoimmunity
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
    
    S.E. Swedo, "Genetics of childhood disorders: XXXIII. Autoimmunity, Part 6: Poststreptococcal autoimmunity", J AM A CHIL, 40(12), 2001, pp. 1479-1482
77. Thienemann, M; Martin, J; Cregger, B; Thompson, HB; Dyer-Friedman, J
    Manual-driven group cognitive-behavioral therapy for adolescents with obsessive-compulsive disorder: A pilot study
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
    
    M. Thienemann et al., "Manual-driven group cognitive-behavioral therapy for adolescents with obsessive-compulsive disorder: A pilot study", J AM A CHIL, 40(11), 2001, pp. 1254-1260
78. Cook, EH; Wagner, KD; March, JS; Biederman, J; Landau, P; Wolkow, R; Messig, M
    Long-term sertraline treatment of children and adolescents with obsessive-compulsive disorder
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
    
    E.H. Cook et al., "Long-term sertraline treatment of children and adolescents with obsessive-compulsive disorder", J AM A CHIL, 40(10), 2001, pp. 1175-1181
79. Brown, CS
    Depression and anxiety disorders
    OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA
    
    C.S. Brown, "Depression and anxiety disorders", OB GYN CLIN, 28(2), 2001, pp. 241
80. Rosqvist, J; Egan, D; Manzo, P; Baer, L; Jenike, MA; Willis, BS
    Home-based behavior therapy for obsessive-compulsive disorder: A case series with data
    JOURNAL OF ANXIETY DISORDERS
    
    J. Rosqvist et al., "Home-based behavior therapy for obsessive-compulsive disorder: A case series with data", J ANXIETY D, 15(5), 2001, pp. 395-400
81. Tukel, R; Keser, V; Karali, NT; Olgun, TO; Calikusu, C
    Comparison of clinical characteristics in trichotillomania and obsessive-compulsive disorder
    JOURNAL OF ANXIETY DISORDERS
    
    R. Tukel et al., "Comparison of clinical characteristics in trichotillomania and obsessive-compulsive disorder", J ANXIETY D, 15(5), 2001, pp. 433-441
82. Foa, EB; Amir, N; Bogert, KVA; Molnar, C; Przeworski, A
    Inflated perception of responsibility for harm in obsessive-compulsive disorder
    JOURNAL OF ANXIETY DISORDERS
    
    E.B. Foa et al., "Inflated perception of responsibility for harm in obsessive-compulsive disorder", J ANXIETY D, 15(4), 2001, pp. 259-275
83. Warren, R; Thomas, JC
    Cognitive-behavior therapy of obsessive-compulsive disorder in private practice: An effectiveness study
    JOURNAL OF ANXIETY DISORDERS
    
    R. Warren e J.C. Thomas, "Cognitive-behavior therapy of obsessive-compulsive disorder in private practice: An effectiveness study", J ANXIETY D, 15(4), 2001, pp. 277-285
84. Mundo, E; Rouillon, F; Figuera, ML; Stigler, M
    Fluvoxamine in obsessive-compulsive disorder: similar efficacy but superior tolerability in comparison with clomipramine
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    
    E. Mundo et al., "Fluvoxamine in obsessive-compulsive disorder: similar efficacy but superior tolerability in comparison with clomipramine", HUM PSYCHOP, 16(6), 2001, pp. 461-468
85. Meiri, G; Ben-Zion, IZ; Greenberg, BD; Murphy, DL; Benjamin, J
    Influence of the serotonin antagonist, metergoline, on the anxiogenic effects of carbon dioxide, and on heart rate and neuroendocrine measures, in healthy volunteers
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    
    G. Meiri et al., "Influence of the serotonin antagonist, metergoline, on the anxiogenic effects of carbon dioxide, and on heart rate and neuroendocrine measures, in healthy volunteers", HUM PSYCHOP, 16(3), 2001, pp. 237-245
86. Nemets, B; Fux, M; Levine, J; Belmaker, RH
    Combination of antidepressant drugs: The case of inositol
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    
    B. Nemets et al., "Combination of antidepressant drugs: The case of inositol", HUM PSYCHOP, 16(1), 2001, pp. 37-43
87. Dyck, IR; Phillips, KA; Warshaw, MG; Dolan, RT; Shea, T; Stout, RL; Massion, AO; Zlotnick, C; Keller, MB
    Patterns of personality pathology in patients with generalized anxiety disorder, panic disorder with and without agoraphobia, and social phobia
    JOURNAL OF PERSONALITY DISORDERS
    
    I.R. Dyck et al., "Patterns of personality pathology in patients with generalized anxiety disorder, panic disorder with and without agoraphobia, and social phobia", J PERS DIS, 15(1), 2001, pp. 60-71
88. Kulisevsky, J; Litvan, I; Berthier, ML; Pascual-Sedano, B; Paulsen, JS; Cummings, JL
    Neuropsychiatric assessment of Gilles de la Tourette patients: Comparativestudy with other hyperkinetic and hypokinetic movement disorders
    MOVEMENT DISORDERS
    
    J. Kulisevsky et al., "Neuropsychiatric assessment of Gilles de la Tourette patients: Comparativestudy with other hyperkinetic and hypokinetic movement disorders", MOVEMENT D, 16(6), 2001, pp. 1098-1104
89. Joel, D
    Open interconnected model of basal ganglia-thalamocortical circuitry and its relevance to the clinical syndrome of Huntington's disease
    MOVEMENT DISORDERS
    
    D. Joel, "Open interconnected model of basal ganglia-thalamocortical circuitry and its relevance to the clinical syndrome of Huntington's disease", MOVEMENT D, 16(3), 2001, pp. 407-423
90. Weidenheim, KM; Goodman, L; Dickson, DW; Gillberg, C; Rastam, M; Rapin, I
    Etiology and pathophysiology of autistic behavior: Clues from two cases with an unusual variant of neuroaxonal dystrophy
    JOURNAL OF CHILD NEUROLOGY
    
    K.M. Weidenheim et al., "Etiology and pathophysiology of autistic behavior: Clues from two cases with an unusual variant of neuroaxonal dystrophy", J CHILD NEU, 16(11), 2001, pp. 809-819
91. Kindt, M; Van den Hout, M
    Selective attention and anxiety: A perspective on developmental issues andthe causal status
    JOURNAL OF PSYCHOPATHOLOGY AND BEHAVIORAL ASSESSMENT
    
    M. Kindt e M. Van den Hout, "Selective attention and anxiety: A perspective on developmental issues andthe causal status", J PSYCHOPAT, 23(3), 2001, pp. 193-202
92. Bejerot, S; Nylander, L; Lindstrom, E
    Autistic traits in obsessive-compulsive disorder
    NORDIC JOURNAL OF PSYCHIATRY
    
    S. Bejerot et al., "Autistic traits in obsessive-compulsive disorder", NORD J PSY, 55(3), 2001, pp. 169-176
93. Rivas-Vazquez, RA
    Antidepressants as first-line agents in the current pharmacotherapy of anxiety disorders
    PROFESSIONAL PSYCHOLOGY-RESEARCH AND PRACTICE
    
    R.A. Rivas-Vazquez, "Antidepressants as first-line agents in the current pharmacotherapy of anxiety disorders", PROF PSYCH, 32(1), 2001, pp. 101-104
94. Chessick, RD
    OCD, OCPD: Acronyms do not make a disease
    PSYCHOANALYTIC INQUIRY
    
    R.D. Chessick, "OCD, OCPD: Acronyms do not make a disease", PSYCHOAN IN, 21(2), 2001, pp. 183-207
95. Tennyson, H; Levine, N
    Neurotropic and psychotropic drugs in dermatology
    DERMATOLOGIC CLINICS
    
    H. Tennyson e N. Levine, "Neurotropic and psychotropic drugs in dermatology", DERM CLIN, 19(1), 2001, pp. 179
96. Marcus, D; Kurlan, R
    Tics and its disorders
    NEUROLOGIC CLINICS
    
    D. Marcus e R. Kurlan, "Tics and its disorders", NEUROL CLIN, 19(3), 2001, pp. 735
97. Masi, G; Toni, C; Perugi, G; Mucci, M; Millepiedi, S; Akiskal, HS
    Anxiety disorders in children and adolescents with bipolar disorder: A neglected comorbidity
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    
    G. Masi et al., "Anxiety disorders in children and adolescents with bipolar disorder: A neglected comorbidity", CAN J PSY, 46(9), 2001, pp. 797-802
98. Carrey, N
    Developmental neurobiology: Implications for pediatric psychopharmacology
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    
    N. Carrey, "Developmental neurobiology: Implications for pediatric psychopharmacology", CAN J PSY, 46(9), 2001, pp. 810-818
99. Reddy, PS; Reddy, YCJ; Srinath, S; Khanna, S; Sheshadri, SP; Girimaji, SR
    A family study of juvenile obsessive-compulsive disorder
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    
    P.S. Reddy et al., "A family study of juvenile obsessive-compulsive disorder", CAN J PSY, 46(4), 2001, pp. 346-351
100. Francobandiera, G
     Olanzapine augmentation of serotonin uptake inhibitors in obsessive-compulsive disorder: An open study
     CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
     
     G. Francobandiera, "Olanzapine augmentation of serotonin uptake inhibitors in obsessive-compulsive disorder: An open study", CAN J PSY, 46(4), 2001, pp. 356-358